May 2019

2019-05-25

Prof. Myśliwiec elected again to be the member of the Board of the Polish Society of Diabetology for the term 2019-2023.

See other news

2025-09-03

Korean Patent Granted for CAR-Treg Therapy

See

2025-08-04

PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007

See

2025-07-31

PolTREG Secures Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial

See

2025-07-29

PolTREG’s Pharmaceutical Manufacturing Facility Now GMP Certified

See

2025-07-04

World-Class Experts Join Immuthera’s Scientific Advisory Board

See

2025-06-20

PolTREG at BIO International Convention 2025

See

2025-06-13

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy

See

2025-05-14

PolTREG Q1 2025 financial results webinar

See